Form 4: Stereotaxis Director Myriam Curet Reports Stock Grant and Disposal

Director Myriam Curet reports the acquisition of restricted share units and disposal of common stock in Stereotaxis, Inc.

Summary

• On July 1, 2024, Myriam Curet, a director of Stereotaxis, Inc., reported transactions involving the company's stock.
• Curet acquired 53,475 restricted share units, each representing the right to receive one share of common stock, at a price of $0.
• Simultaneously, Curet disposed of 53,475 shares of common stock.
• Following these transactions, Curet beneficially owns 244,945 shares of Stereotaxis common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Future Outlook

The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in the healthcare technology industry. It provides transparency to investors regarding the actions of company leadership.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding director compensation and stock ownership.
• The vesting schedule of the restricted share units aligns the director's interests with the long-term performance of the company.

Key Dates